Johnson & Johnson JNJ
NYSE JNJ
$261.49 +5.00 (+1.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Long-Term Investments (2009)

Updated

Johnson & Johnson (JNJ) recorded Long-Term Investments of $19 million in Q3 2010, up 5.6% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Long-Term Investments (2009) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn -
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 266.00 Mn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 297.00 Mn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn -
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 1.56 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 5.79 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2009 19.00 Mn
Jun 28, 2009 18.00 Mn
API Access

Johnson & Johnson Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=JNJ&period=max&api_key=YOUR_API_KEY